March 22, 2024 07:10 AM EDT

Novo's weekly insulin secures CHMP thumbs-up as FDA decision looms

Katherine Lewin

News Reporter

Novo Nordisk is another step closer to launching its once-weekly insulin icodec now that the European Medicines Agency’s Committee for Medicinal Products for Human Use …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Novo's weekly insulin secures CHMP thumbs-up as FDA decision looms

Katherine Lewin

News Reporter

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

BridgeBio shares promising results in trial of Canavan disease gene therapy

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

Icon's quarterly earnings hit by biotech and pharma pullback

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

Novo's week­ly in­sulin se­cures CHMP thumbs-up as FDA de­ci­sion looms

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Novo's weekly insulin secures CHMP thumbs-up as FDA decision looms